Abstract 7489: Unraveling a new ECM stiffening function of the axon guidance molecule Netrin-1

Abstract State of the art The extracellular matrix (ECM) is a complex and dynamic network composed of core structural proteins and matrisome-associated components. Under physiological conditions, ECM homeostasis contributes to the maintenance of natural tissue stiffness. However, disruption of this balance can lead to abnormal stiffening, a hallmark observed in various pathological conditions, including fibrosis and cancer. Our laboratory investigates the role of the dependence receptor ligand Netrin-1 (NTN1), a neuronal guidance protein predominantly expressed during early developmental stages. Intriguingly, NTN1 is frequently re-expressed in tumors, where its presence has been correlated with increased ECM stiffness. As such, our research aims to elucidate the role of NTN1 in ECM remodelling and stiffening. Methodology and resultsUsing atomic force microscopy (AFM) on inert Matrigel matrices, we observed a marked increase in stiffness upon supplementation with recombinant Netrin-1 (rNTN1). This stiffening effect was reversed by NP137, a monoclonal antibody targeting NTN1. Structural analyses via immunofluorescence staining for laminin-111 and rNTN1, alongside scanning electron microscopy (SEM), revealed a significant reduction in pore size in the presence of rNTN1. Complementary in silico analysis using PEPPI software indicated strong interactions between NTN1 and key ECM components such as Nidogen and Laminin. PerspectivesTo validate these predicted interactions, we performed biolayer interferometry with various ECM proteins. Furthermore, 3D cultures models of MCF10A normal mammary epithelial cells exposed to NTN1 displayed a phenotypic transition toward a more mesenchymal and invasive state. Interestingly, knockdown of NTN1 receptors did not prevent this phenotypic shift, suggesting a novel receptor-independent function for NTN1 in promoting cell invasiveness through direct modulation of ECM stiffness. Ongoing structural analyses are being conducted on fibroblast-derived matrices, with and without endogenous Netrin-1 expression, to evaluate its potential remodeling effects on collagen IV and fibronectin networks. In parallel, these matrices are utilized in functional assays to investigate how Netrin-1 ECM impact, influences cellular behaviours and transcriptional activity, using a range of experimental approaches. Citation Format: Gaëtan THIVOLLE LIOUX, Laurent Fattet, PATRICK MEHLEN, . Unraveling a new ECM stiffening function of the axon guidance molecule Netrin-1 [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 7489.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-7489
Primary Topic
Axon Guidance and Neuronal Signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 7489: Unraveling a new ECM stiffening function of the axon guidance molecule Netrin-1

Laurent Fattet, Gaëtan Thivolle Lioux, Patrick Mehlen
Cancer Research
Axon Guidance and Neuronal Signaling
article

Abstract 7489: Unraveling a new ECM stiffening function of the axon guidance molecule Netrin-1

Laurent Fattet, Gaëtan Thivolle Lioux, Patrick Mehlen
article en

Abstract

Abstract State of the art The extracellular matrix (ECM) is a complex and dynamic network composed of core structural proteins and matrisome-associated components. Under physiological conditions, ECM homeostasis contributes to the maintenance of natural tissue stiffness. However, disruption of this balance can lead to abnormal stiffening, a hallmark observed in various pathological conditions, including fibrosis and cancer. Our laboratory investigates the role of the dependence receptor ligand Netrin-1 (NTN1), a neuronal guidance protein predominantly expressed during early developmental stages. Intriguingly, NTN1 is frequently re-expressed in tumors, where its presence has been correlated with increased ECM stiffness. As such, our research aims to elucidate the role of NTN1 in ECM remodelling and stiffening. Methodology and resultsUsing atomic force microscopy (AFM) on inert Matrigel matrices, we observed a marked increase in stiffness upon supplementation with recombinant Netrin-1 (rNTN1). This stiffening effect was reversed by NP137, a monoclonal antibody targeting NTN1. Structural analyses via immunofluorescence staining for laminin-111 and rNTN1, alongside scanning electron microscopy (SEM), revealed a significant reduction in pore size in the presence of rNTN1. Complementary in silico analysis using PEPPI software indicated strong interactions between NTN1 and key ECM components such as Nidogen and Laminin. PerspectivesTo validate these predicted interactions, we performed biolayer interferometry with various ECM proteins. Furthermore, 3D cultures models of MCF10A normal mammary epithelial cells exposed to NTN1 displayed a phenotypic transition toward a more mesenchymal and invasive state. Interestingly, knockdown of NTN1 receptors did not prevent this phenotypic shift, suggesting a novel receptor-independent function for NTN1 in promoting cell invasiveness through direct modulation of ECM stiffness. Ongoing structural analyses are being conducted on fibroblast-derived matrices, with and without endogenous Netrin-1 expression, to evaluate its potential remodeling effects on collagen IV and fibronectin networks. In parallel, these matrices are utilized in functional assays to investigate how Netrin-1 ECM impact, influences cellular behaviours and transcriptional activity, using a range of experimental approaches. Citation Format: Gaëtan THIVOLLE LIOUX, Laurent Fattet, PATRICK MEHLEN, . Unraveling a new ECM stiffening function of the axon guidance molecule Netrin-1 [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 7489.

Cancer ResearchVol. 86(7_Supplement)
Centre de Recherche en Cancérologie de Lyon (FR)
Openalex Percentile: Top 6%
Axon Guidance and Neuronal Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.